SIGA (SIGA) 10-Q 4 Aug 22 2022 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2022	Jul. 22, 2022
Document Information [Line Items]
Entity Central Index Key	0001010086
Entity Registrant Name	Siga Technologies INC
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2022
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2022
Document Transition Report	false
Entity File Number	0-23047
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	13-3864870
Entity Address, Address Line One	31 East 62nd Street
Entity Address, Postal Zip Code	10065
Entity Address, City or Town	New York
Entity Address, State or Province	NY
City Area Code	212
Local Phone Number	672-9100
Title of 12(b) Security	common stock, $.0001 par value
Trading Symbol	SIGA
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		73,024,147

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents	$ 114,530,926	$ 103,138,819
Accounts receivable	19,598,122	83,650,450
Inventory	16,431,382	19,510,379
Prepaid expenses and other current assets	3,083,027	2,453,444
Total current assets	153,643,457	208,753,092
Property, plant and equipment, net	2,109,720	2,365,957
Deferred income taxes, net	3,039,814	2,422,607
Goodwill	898,334	898,334
Other assets	249,170	286,585
Total assets	159,940,495	214,726,575
Current liabilities
Accounts payable	1,214,617	2,028,004
Accrued expenses and other current liabilities	14,844,830	9,252,812
Income tax payable	634,619	19,207,042
Total current liabilities	16,694,066	30,487,858
Warrant liability	0	6,521,441
Other liabilities	3,477,575	3,402,869
Total liabilities	20,171,641	40,412,168
Commitments and contingencies
Stockholders’ equity
Common stock ($.0001 par value, 600,000,000 shares authorized, 73,024,147 and 73,543,602, issued and outstanding at June 30, 2022 and December 31, 2021, respectively)	7,302	7,354
Additional paid-in capital	232,942,666	226,070,308
Accumulated deficit	(93,181,114)	(51,763,255)
Total stockholders’ equity	139,768,854	174,314,407
Total liabilities and stockholders’ equity	$ 159,940,495	$ 214,726,575

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Jun. 30, 2022	Dec. 31, 2021
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	600,000,000	600,000,000
Common stock, shares issued (in shares)	73,024,147	73,543,602
Common stock, shares outstanding (in shares)	73,024,147	73,543,602

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Revenues
Total revenues	$ 16,667,045	$ 8,653,289	$ 27,206,345	$ 13,467,033
Operating expenses
Cost of sales and supportive services	882,096	995,990	5,602,212	1,246,838
Selling, general and administrative	5,874,139	5,392,226	9,585,427	9,641,744
Research and development	6,840,099	2,263,971	10,386,876	4,566,756
Total operating expenses	13,596,334	8,652,187	25,574,515	15,455,338
Operating income/(loss)	3,070,711	1,102	1,631,830	(1,988,305)
Gain from change in fair value of warrant liability	49,559	442,269	400,663	1,361,070
Other income, net	72,373	24,235	95,694	49,803
Income/(loss) before income taxes	3,192,643	467,606	2,128,187	(577,432)
Provision for income taxes	(1,155,581)	(298,406)	(452,175)	(65,473)
Net and comprehensive income/(loss)	$ 2,037,062	$ 169,200	$ 1,676,012	$ (642,905)
Basic income/(loss) per share (in dollars per share)	$ 0.03	$ 0	$ 0.02	$ (0.01)
Diluted income/(loss) per share (in dollars per share)	$ 0.03	$ 0	$ 0.02	$ (0.03)
Weighted average shares outstanding: basic (in shares)	72,678,333	75,810,641	72,873,366	76,281,211
Weighted average shares outstanding: diluted (in shares)	73,332,888	76,660,054	73,699,226	77,128,973
Product Sales and Supportive Services [Member]
Revenues
Total revenues	$ 8,615,765	$ 6,924,162	$ 15,936,637	$ 10,447,505
Research and Development [Member]
Revenues
Total revenues	$ 8,051,280	$ 1,729,127	$ 11,269,708	$ 3,019,528

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash flows from operating activities:
Net income (loss)	$ 1,676,012	$ (642,905)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and other amortization	256,237	264,834
Gain on change in fair value of warrant liability	(400,663)	(1,361,070)
Stock-based compensation	764,208	713,817
Write down of inventory, net	157,740	630,707
Deferred income taxes, net	(617,207)	(187,420)
Changes in assets and liabilities:
Accounts receivable	64,052,328	(3,865,872)
Inventory	2,921,257	34,921
Prepaid expenses and other assets	(592,168)	622,109
Accounts payable, accrued expenses and other liabilities	1,582,679	(1,927,150)
Income tax payable	(18,572,423)	(892,148)
Deferred revenue	3,270,658	373,593
Net cash provided by/(used in) operating activities	54,498,658	(6,236,584)
Cash flows from investing activities:
Capital expenditures	0	(24,424)
Cash used in investing activities	0	(24,424)
Cash flows from financing activities:
Payment of employee tax obligations for common stock tendered	(12,533)	(13,361)
Repurchase of common stock	(10,149,704)	(13,129,858)
Payment of dividend	(32,944,314)	0
Cash used in financing activities	(43,106,551)	(13,143,219)
Net increase/(decrease) in cash, cash equivalents and restricted cash	11,392,107	(19,404,227)
Cash, cash equivalents and restricted cash at the beginning of period	103,138,819	117,890,240
Cash and cash equivalents at end of period	114,530,926	98,486,013
Supplemental disclosure of non-cash financing activities:
Conversion of warrant to common stock	$ 6,120,778	$ 0

Note 1 - Condensed Consolidated

Note 1 - Condensed Consolidated Financial Statements	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	1. Condensed Consolidated Financial Statements The financial statements of SIGA Technologies, Inc. (“we,” “our,” “us,” “SIGA” or the “Company”) are presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and the rules and regulations of the Securities and Exchange Commission (the “SEC”) for quarterly reports on Form 10 December 31, 2021 2021 10 March 3, 2022 ( "2021 10 not 2021 10 2021 not three six June 30, 2022 not

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Significant Accounting Policies [Text Block]	2. Revenue Recognition All of the Company’s revenue is derived from long-term contracts that span multiple years. The Company accounts for revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers 606” June 30, 2022 Note 3 five six June 30, 2022 not three Performance Obligations A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in ASC 606. Contract modifications may not The Company’s performance obligations are satisfied over time as work progresses or at a point in time. All of the Company’s revenue related to current research and development performance obligations is recognized over time, because the customer simultaneously receives and consumes the benefits provided by the services as the Company performs these services. The Company recognizes revenue related to these services based on the progress toward complete satisfaction of the performance obligation and measures this progress under an input method, which is based on the Company’s cost incurred relative to total estimated costs. Under this method, progress is measured based on the cost of resources consumed (i.e., cost of third third Contract Balances The timing of revenue recognition, billings and cash collections may June 30, 2022 six June 30, 2022 Repurchase of shares When shares recognized as equity are repurchased, the amount of the consideration paid, which includes directly attributable costs, is recognized as a deduction from equity. The excess of the purchase price above par value of repurchased shares that are retired is presented as an increase to accumulated deficit (or a reduction of retained earnings, if any).

Note 3 - Procurement Contracts

Note 3 - Procurement Contracts and Research Agreements	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Procurement Contract and Research Agreements [Text Block]	3. 19C On September 10, 2018, June 30, 2022 "19C five may ten 19C The base period of performance specifies potential payments of approximately $51.7 million for the following activities: payments of approximately $11.1 million for the delivery of approximately 35,700 courses of oral TPOXX® to the Strategic Stockpile; payments of $8.0 million for the manufacture of 20,000 courses of final drug product of IV TPOXX® ("IV FDP"), of which $3.2 million of payments are related to the manufacture of bulk drug substance ("IV BDS") to be used in the manufacture of IV FDP; payments of approximately $32.0 million to fund advanced development of IV TPOXX®; and payments of approximately $0.6 million for supportive procurement activities. As of June 30, 2022 December 31, 2021, six June 30, 2022 The options that have been exercised to date provide for payments up to approximately $239.7 million. There are exercised options for the following activities: payments up to $11.2 million for the procurement of raw materials used in the 2020 June 30, 2022 2021; Unexercised options specify potential payments up to approximately $311.1 million in total (if all such options are exercised). There are options for the following activities: payments of up to $225.1 million for the delivery of oral TPOXX® to the Strategic Stockpile; payments of up to $76.8 million for the manufacture of courses of IV FDP, of which up to $30.7 million of payments would be paid upon the manufacture of IV BDS to be used in the manufacture of IV FDP; payments of up to approximately $3.6 million to fund post-marketing activities for IV TPOXX®; and payments of up to approximately $5.6 million for supportive procurement activities. The options related to IV TPOXX® are divided into two may none 19C three three not 64,000 Revenues in connection with the 19C 19C three June 30, 2022 2021 six June 30, 2022 2021 six June 30, 2022 no three June 30, 2022 three six June 30, 2021 U.S. Department of Defense Procurement Contract ( DoD Contract ) On May 12, 2022, second 2022, International Procurement Contracts This year, through July 31, ten three June 30, 2022. On January 13, 2021, five March 2022 July 2022, 2022, No first six 2022. July 2022, July 31, 2022, July, On April 3, 2020, four 2022, No first six 2022. June 30, 2022, The above-listed contract awards were coordinated between SIGA and Meridian under the international promotion agreement (as amended, the "International Promotion Agreement") that was entered into by the parties on June 3, 2019. Under the terms of the International Promotion Agreement, Meridian was granted exclusive rights to market, advertise, promote, offer for sale, or sell oral TPOXX® in a field of use specified in the International Promotion Agreement in all geographic regions except for the United States (the “Territory”), and Meridian has agreed not The fee Meridian retains pursuant to the International Promotion Agreement is a specified percentage of the collected proceeds of sales of oral TPOXX® net of certain expenses, for calendar years in which customer collected amounts net of such expenses are less than or equal to a specified threshold, and a higher specified percentage of such collected net proceeds for calendar years in which such net collected amounts exceed the specified threshold. It is probable that we will exceed the specified threshold in 2022 2022. Revenue in connection with international procurement contracts for the delivery of product are recognized at a point in time on a gross basis, as the Company acts as the principal in the transaction. During the three six June 30, 2022 three six June 30, 2021 Research Agreements and Grants In July 2019, January 31, 2025. June 30, 2022 three June 30, 2022 2021 six June 30, 2022 2021 Contracts and grants include, among other things, options that may may not may not

Note 4 - Inventory

Note 4 - Inventory	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Inventory Disclosure [Text Block]	4. Inventory Inventory includes costs related to the manufacture of TPOXX®. Inventory consisted of the following: As of June 30, 2022 December 31, 2021 Raw materials $ 22,047 $ 22,047 Work in-process 9,287,024 17,453,358 Finished goods 7,122,311 2,034,974 Inventory $ 16,431,382 $ 19,510,379

Note 5 - Property, Plant and Eq

Note 5 - Property, Plant and Equipment	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	5. Property, Plant and Equipment Property, plant and equipment consisted of the following: As of June 30, 2022 December 31, 2021 Leasehold improvements $ 2,420,028 $ 2,420,028 Computer equipment 473,386 511,062 Furniture and fixtures 377,859 377,859 Operating lease right-of-use assets 3,678,647 3,678,647 6,949,920 6,987,596 Less - accumulated depreciation and amortization (4,840,200 ) (4,621,639 ) Property, plant and equipment, net $ 2,109,720 $ 2,365,957 Depreciation and amortization expense on property, plant, and equipment was $0.3 million for each of the six June 30, 2022 2021

Note 6 - Accrued Expenses and O

Note 6 - Accrued Expenses and Other Current Liabilities	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Accrued Expenses and Other Liabilities [Text Block]	6. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following: As of June 30, 2022 December 31, 2021 Deferred revenue $ 7,035,354 $ 3,764,696 Research and development vendor costs 3,657,403 256,397 Compensation 1,424,067 2,811,700 Other 934,745 938,082 Professional fees 808,246 527,026 Lease liability, current portion 507,140 466,830 Inventory 477,875 488,081 Accrued expenses and other current liabilities $ 14,844,830 $ 9,252,812

Note 7 - Financial Instruments

Note 7 - Financial Instruments	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Financial Instruments Disclosure [Text Block]	7. Financial Instruments 2016 On September 2, 2016, 2020. September 2, 2016 ten December 31, 2021. During the three June 30, 2022, June 30, 2022 Note 8 three June 30, 2022 As of December 31, 2021, 1.21%; no

Note 8 - Fair Value of Financia

Note 8 - Fair Value of Financial Instruments	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Fair Value Disclosures [Text Block]	8. Fair Value of Financial Instruments The carrying value of cash equivalents, accounts receivable, accounts payable, accrued expenses and other current liabilities, and income tax payable approximates fair value due to the relatively short maturity of these instruments. Prior to being fully exercised, common stock warrants, which were classified as a liability, were recorded at their fair market value as of each reporting period. The measurement of fair value requires the use of techniques based on observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. The inputs create the following fair value hierarchy: • Level 1 • Level 2 not • Level 3 third There were no six June 30, 2022 June 30, 2022 December 31, 2021 1 2 June 30, 2022 The following table presents changes in the liability-classified warrant measured at fair value using Level 3 Fair Value Measurements of Level 3 liability-classified warrant Warrant liability at December 31, 2021 $ 6,521,441 Decrease in fair value of Warrant liability (400,663 ) Exercise of Warrant (6,120,778 ) Warrant liability at June 30, 2022 $ -

Note 9 - Per Share Data

Note 9 - Per Share Data	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Earnings Per Share [Text Block]	9. Per Share Data The Company computes, presents and discloses earnings per share in accordance with the authoritative guidance, which specifies the computation, presentation and disclosure requirements for earnings per share of entities with publicly held common stock or potential common stock. The objective of basic EPS is to measure the performance of an entity over the reporting period by dividing income (loss) by the weighted average shares outstanding. The objective of diluted EPS is consistent with that of basic EPS, except that it also gives effect to all potentially dilutive common shares outstanding during the period. The following is a reconciliation of the basic and diluted loss per share computation: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Net income/(loss) for basic earnings per share $ 2,037,062 $ 169,200 $ 1,676,012 $ (642,905 ) Less: Change in fair value of warrants and cash-based RSUs 49,559 428,128 400,663 1,346,929 Net income/(loss), adjusted for change in fair value of warrants and cash-based RSUs for diluted earnings per share $ 1,987,503 $ (258,928 ) $ 1,275,349 $ (1,989,834 ) Weighted-average shares 72,678,333 75,810,641 72,873,366 76,281,211 Effect of potential common shares 654,555 849,413 825,860 847,762 Weighted-average shares: diluted 73,332,888 76,660,054 73,699,226 77,128,973 Income/(loss) per share: basic $ 0.03 $ 0.00 $ 0.02 $ (0.01 ) Income/(loss) per share: diluted $ 0.03 $ (0.00 ) $ 0.02 $ (0.03 ) For the three six June 30, 2022 not three six June 30, 2022 three six June 30, 2022 For the three six June 30, 2021 Three Months Ended June 30, Six Months Ended June 30, 2021 2021 Stock options 123,667 154,617 Restricted stock units (stock settled) 166,683 165,309

Note 10 - Commitments and Conti

Note 10 - Commitments and Contingencies	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	10. Commitments and Contingencies From time to time, we may not Purchase Commitments In the course of our business, the Company regularly enters into agreements with third not June 30, 2022

Note 11 - Related Party Transac

Note 11 - Related Party Transactions	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	11. Related Party Transactions Board of Directors and Outside Counsel A former member of the Company’s Board of Directors who did not 2021 not three June 30, 2022 2021 six June 30, 2022 six June 30, 2021 June 30, 2022 Real Estate Leases On May 26, 2017, ten 31 62 nd first sixty-three first six first sixty-fourth first second five three six June 30, 2022

Note 12 - Revenues by Geographi

Note 12 - Revenues by Geographic Region	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	12. Revenues by Geographic Region Revenues by geographic region were as follows: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 United States $ 11,715,302 $ 1,673,083 $ 22,254,602 $ 2,911,455 International Asia-Pacific 4,929,423 — 4,929,423 — Canada — 6,980,206 — 10,555,578 Other 22,320 — 22,320 — Total International 4,951,743 6,980,206 4,951,743 10,555,578 Total revenues $ 16,667,045 $ 8,653,289 $ 27,206,345 $ 13,467,033

Note 13 - Income Taxes

Note 13 - Income Taxes	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Income Tax Disclosure [Text Block]	13. Income Taxes The Company’s provision for income taxes consists of federal and state taxes, as applicable, in amounts necessary to align the Company’s year-to-date tax provision with the effective rate that it expects to achieve for the full year. Each quarter the Company updates its estimate of the annual effective tax rate and records cumulative adjustments as necessary. For the three June 30, 2022 2021 For the six June 30, 2022 2021 The effective tax rate for the three June 30, 2022 three June 30, 2021 three June 30, 2022 162 The effective tax rate for the six June 30, 2022 six June 30, 2021 six June 30, 2022 162

Note 14 - Equity

Note 14 - Equity	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	14. The tables below present changes in stockholders' equity for the three six June 30, 2022 2021 Common Stock Additional Paid-in Accumulated Other Comprehensive Total Stockholders' Shares Amount Capital Deficit Income Equity Balances at March 31, 2022 72,566,367 $ 7,256 $ 226,426,529 $ (58,696,989 ) $ — $ 167,736,796 Net income — — 2,037,062 — 2,037,062 Repurchase of common stock (494,979 ) (49 ) — (3,576,873 ) — (3,576,922 ) Issuance of common stock upon vesting of RSUs 127,856 13 (13 ) — — — Issuance of common stock upon exercise of warrants 824,903 82 6,120,696 — — 6,120,778 Cash dividend ($ 0.45 — — — (32,944,314 ) — (32,944,314 ) Stock-based compensation — — 395,454 — — 395,454 Balances at June 30, 2022 73,024,147 $ 7,302 $ 232,942,666 $ (93,181,114 ) $ — $ 139,768,854 Common Stock Additional Paid-in Accumulated Other Comprehensive Total Stockholders' Shares Amount Capital Deficit Income Equity Balances at December 31, 2021 73,543,602 $ 7,354 $ 226,070,308 $ (51,763,255 ) $ — $ 174,314,407 Net income — — — 1,676,012 — 1,676,012 Repurchase of common stock (1,474,781 ) (147 ) — (10,149,557 ) — (10,149,704 ) Payment of common stock tendered for employee stock-based compensation tax obligations (1,973 ) — (12,533 ) — — (12,533 ) Issuance of common stock upon vesting of RSUs 132,396 13 (13 ) — — — Issuance of common stock upon exercise of warrants 824,903 82 6,120,696 — 6,120,778 Cash dividend ($ 0.45 — — (32,944,314 ) (32,944,314 ) Stock-based compensation — — 764,208 — — 764,208 Balances at June 30, 2022 73,024,147 $ 7,302 $ 232,942,666 $ (93,181,114 ) $ — $ 139,768,854 Common Stock Additional Paid-in Accumulated Other Comprehensive Total Stockholders' Shares Amount Capital Deficit Income Equity Balances at March 31, 2021 76,240,439 $ 7,625 $ 225,211,481 $ (102,534,239 ) $ — $ 122,684,867 Net income — — — 169,200 — 169,200 Repurchase of common stock (956,022 ) (96 ) — (6,600,414 ) — (6,600,510 ) Issuance of common stock upon vesting of RSUs 105,000 10 (10 ) — — — Stock-based compensation — — 467,405 — — 467,405 Balances at June 30, 2021 75,389,417 $ 7,539 $ 225,678,876 $ (108,965,453 ) $ — $ 116,720,962 Common Stock Additional Paid-in Accumulated Other Comprehensive Total Stockholders' Shares Amount Capital Deficit Income Equity Balances at December 31, 2020 77,195,704 $ 7,720 $ 224,978,430 $ (95,192,881 ) $ — $ 129,793,269 Net loss — — — (642,905 ) — (642,905 ) Repurchase of common stock (1,913,927 ) (191 ) — (13,129,667 ) — (13,129,858 ) Payment of common stock tendered for employee stock-based compensation tax obligations (1,902 ) — (13,361 ) — — (13,361 ) Issuance of common stock upon vesting of RSUs 109,542 10 (10 ) — — — Stock-based compensation — — 713,817 — — 713,817 Balances at June 30, 2021 75,389,417 $ 7,539 $ 225,678,876 $ (108,965,453 ) $ — $ 116,720,962 On August 2, 2021, may December 31, 2023. fourth 2021. may may 10b5 1 1934, three six June 30, 2022 Prior to the effective date of the New Repurchase Authorization, the Company repurchased shares under a program that was announced in March 2020. three June 30, 2021 six June 30, 2021 On May 5, 2022, June 2, 2022 May 17, 2022.

Note 15 - Leases

Note 15 - Leases	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Lessee, Operating Leases [Text Block]	15. The Company leases its Corvallis, Oregon, facilities and office space under an operating lease, which was signed on November 3, 2017 January 1, 2018. December 31, 2019 two one two three second 2019, first December 31, 2021. second 2021, second December 31, 2024. second second 2021. On May 26, 2017 ten no Operating lease costs totaled $0.1 million for each of the three June 30, 2022 2021 six June 30, 2022 2021 three June 30, 2022 2021 six June 30, 2022 2021 June 30, 2022 Future cash flows under operating leases as of June 30, 2022 2022 $ 272,625 2023 669,048 2024 678,627 2025 406,994 2026 409,971 Thereafter 165,916 Total undiscounted cash flows under leases 2,603,181 Less: Imputed interest (251,805 ) Present value of lease liabilities $ 2,351,376 As of June 30, 2022

Significant Accounting Policies

Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Revenue from Contract with Customer [Policy Text Block]	Revenue Recognition All of the Company’s revenue is derived from long-term contracts that span multiple years. The Company accounts for revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers 606” June 30, 2022 Note 3 five six June 30, 2022 not three Performance Obligations A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in ASC 606. Contract modifications may not The Company’s performance obligations are satisfied over time as work progresses or at a point in time. All of the Company’s revenue related to current research and development performance obligations is recognized over time, because the customer simultaneously receives and consumes the benefits provided by the services as the Company performs these services. The Company recognizes revenue related to these services based on the progress toward complete satisfaction of the performance obligation and measures this progress under an input method, which is based on the Company’s cost incurred relative to total estimated costs. Under this method, progress is measured based on the cost of resources consumed (i.e., cost of third third Contract Balances The timing of revenue recognition, billings and cash collections may June 30, 2022 six June 30, 2022
Stockholders' Equity, Policy [Policy Text Block]	Repurchase of shares When shares recognized as equity are repurchased, the amount of the consideration paid, which includes directly attributable costs, is recognized as a deduction from equity. The excess of the purchase price above par value of repurchased shares that are retired is presented as an increase to accumulated deficit (or a reduction of retained earnings, if any).

Note 4 - Inventory (Tables)

Note 4 - Inventory (Tables)	6 Months Ended
	Jun. 30, 2022
Notes Tables
Schedule of Inventory, Current [Table Text Block]	As of June 30, 2022 December 31, 2021 Raw materials $ 22,047 $ 22,047 Work in-process 9,287,024 17,453,358 Finished goods 7,122,311 2,034,974 Inventory $ 16,431,382 $ 19,510,379

Note 5 - Property, Plant and _2

Note 5 - Property, Plant and Equipment (Tables)	6 Months Ended
	Jun. 30, 2022
Notes Tables
Property, Plant and Equipment [Table Text Block]	As of June 30, 2022 December 31, 2021 Leasehold improvements $ 2,420,028 $ 2,420,028 Computer equipment 473,386 511,062 Furniture and fixtures 377,859 377,859 Operating lease right-of-use assets 3,678,647 3,678,647 6,949,920 6,987,596 Less - accumulated depreciation and amortization (4,840,200 ) (4,621,639 ) Property, plant and equipment, net $ 2,109,720 $ 2,365,957

Note 6 - Accrued Expenses and_2

Note 6 - Accrued Expenses and Other Current Liabilities (Tables)	6 Months Ended
	Jun. 30, 2022
Notes Tables
Accrued Expenses and Other Current Liabilities [Table Text Block]	As of June 30, 2022 December 31, 2021 Deferred revenue $ 7,035,354 $ 3,764,696 Research and development vendor costs 3,657,403 256,397 Compensation 1,424,067 2,811,700 Other 934,745 938,082 Professional fees 808,246 527,026 Lease liability, current portion 507,140 466,830 Inventory 477,875 488,081 Accrued expenses and other current liabilities $ 14,844,830 $ 9,252,812

Note 8 - Fair Value of Financ_2

Note 8 - Fair Value of Financial Instruments (Tables)	6 Months Ended
	Jun. 30, 2022
Notes Tables
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	Fair Value Measurements of Level 3 liability-classified warrant Warrant liability at December 31, 2021 $ 6,521,441 Decrease in fair value of Warrant liability (400,663 ) Exercise of Warrant (6,120,778 ) Warrant liability at June 30, 2022 $ -

Note 9 - Per Share Data (Tables

Note 9 - Per Share Data (Tables)	6 Months Ended
	Jun. 30, 2022
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Net income/(loss) for basic earnings per share $ 2,037,062 $ 169,200 $ 1,676,012 $ (642,905 ) Less: Change in fair value of warrants and cash-based RSUs 49,559 428,128 400,663 1,346,929 Net income/(loss), adjusted for change in fair value of warrants and cash-based RSUs for diluted earnings per share $ 1,987,503 $ (258,928 ) $ 1,275,349 $ (1,989,834 ) Weighted-average shares 72,678,333 75,810,641 72,873,366 76,281,211 Effect of potential common shares 654,555 849,413 825,860 847,762 Weighted-average shares: diluted 73,332,888 76,660,054 73,699,226 77,128,973 Income/(loss) per share: basic $ 0.03 $ 0.00 $ 0.02 $ (0.01 ) Income/(loss) per share: diluted $ 0.03 $ (0.00 ) $ 0.02 $ (0.03 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	Three Months Ended June 30, Six Months Ended June 30, 2021 2021 Stock options 123,667 154,617 Restricted stock units (stock settled) 166,683 165,309

Note 12 - Revenues by Geograp_2

Note 12 - Revenues by Geographic Region (Tables)	6 Months Ended
	Jun. 30, 2022
Notes Tables
Revenue from External Customers by Geographic Areas [Table Text Block]	Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 United States $ 11,715,302 $ 1,673,083 $ 22,254,602 $ 2,911,455 International Asia-Pacific 4,929,423 — 4,929,423 — Canada — 6,980,206 — 10,555,578 Other 22,320 — 22,320 — Total International 4,951,743 6,980,206 4,951,743 10,555,578 Total revenues $ 16,667,045 $ 8,653,289 $ 27,206,345 $ 13,467,033

Note 14 - Equity (Tables)

Note 14 - Equity (Tables)	6 Months Ended
	Jun. 30, 2022
Notes Tables
Schedule of Stockholders Equity [Table Text Block]	Common Stock Additional Paid-in Accumulated Other Comprehensive Total Stockholders' Shares Amount Capital Deficit Income Equity Balances at March 31, 2022 72,566,367 $ 7,256 $ 226,426,529 $ (58,696,989 ) $ — $ 167,736,796 Net income — — 2,037,062 — 2,037,062 Repurchase of common stock (494,979 ) (49 ) — (3,576,873 ) — (3,576,922 ) Issuance of common stock upon vesting of RSUs 127,856 13 (13 ) — — — Issuance of common stock upon exercise of warrants 824,903 82 6,120,696 — — 6,120,778 Cash dividend ($ 0.45 — — — (32,944,314 ) — (32,944,314 ) Stock-based compensation — — 395,454 — — 395,454 Balances at June 30, 2022 73,024,147 $ 7,302 $ 232,942,666 $ (93,181,114 ) $ — $ 139,768,854 Common Stock Additional Paid-in Accumulated Other Comprehensive Total Stockholders' Shares Amount Capital Deficit Income Equity Balances at December 31, 2021 73,543,602 $ 7,354 $ 226,070,308 $ (51,763,255 ) $ — $ 174,314,407 Net income — — — 1,676,012 — 1,676,012 Repurchase of common stock (1,474,781 ) (147 ) — (10,149,557 ) — (10,149,704 ) Payment of common stock tendered for employee stock-based compensation tax obligations (1,973 ) — (12,533 ) — — (12,533 ) Issuance of common stock upon vesting of RSUs 132,396 13 (13 ) — — — Issuance of common stock upon exercise of warrants 824,903 82 6,120,696 — 6,120,778 Cash dividend ($ 0.45 — — (32,944,314 ) (32,944,314 ) Stock-based compensation — — 764,208 — — 764,208 Balances at June 30, 2022 73,024,147 $ 7,302 $ 232,942,666 $ (93,181,114 ) $ — $ 139,768,854 Common Stock Additional Paid-in Accumulated Other Comprehensive Total Stockholders' Shares Amount Capital Deficit Income Equity Balances at March 31, 2021 76,240,439 $ 7,625 $ 225,211,481 $ (102,534,239 ) $ — $ 122,684,867 Net income — — — 169,200 — 169,200 Repurchase of common stock (956,022 ) (96 ) — (6,600,414 ) — (6,600,510 ) Issuance of common stock upon vesting of RSUs 105,000 10 (10 ) — — — Stock-based compensation — — 467,405 — — 467,405 Balances at June 30, 2021 75,389,417 $ 7,539 $ 225,678,876 $ (108,965,453 ) $ — $ 116,720,962 Common Stock Additional Paid-in Accumulated Other Comprehensive Total Stockholders' Shares Amount Capital Deficit Income Equity Balances at December 31, 2020 77,195,704 $ 7,720 $ 224,978,430 $ (95,192,881 ) $ — $ 129,793,269 Net loss — — — (642,905 ) — (642,905 ) Repurchase of common stock (1,913,927 ) (191 ) — (13,129,667 ) — (13,129,858 ) Payment of common stock tendered for employee stock-based compensation tax obligations (1,902 ) — (13,361 ) — — (13,361 ) Issuance of common stock upon vesting of RSUs 109,542 10 (10 ) — — — Stock-based compensation — — 713,817 — — 713,817 Balances at June 30, 2021 75,389,417 $ 7,539 $ 225,678,876 $ (108,965,453 ) $ — $ 116,720,962

Note 15 - Leases (Tables)

Note 15 - Leases (Tables)	6 Months Ended
	Jun. 30, 2022
Notes Tables
Lessee, Operating Lease, Liability, Maturity [Table Text Block]	2022 $ 272,625 2023 669,048 2024 678,627 2025 406,994 2026 409,971 Thereafter 165,916 Total undiscounted cash flows under leases 2,603,181 Less: Imputed interest (251,805 ) Present value of lease liabilities $ 2,351,376

Note 2 - Summary of Significa_2

Note 2 - Summary of Significant Accounting Policies (Details Textual) $ in Millions	6 Months Ended
	Jun. 30, 2022 USD ($)
Revenue, Remaining Performance Obligation, Amount	$ 64.8
Contract with Customer, Asset, after Allowance for Credit Loss, Total	14
Contract with Customer, Liability, Revenue Recognized	$ 3

Note 3 - Procurement Contract_2

Note 3 - Procurement Contracts and Research Agreements (Details Textual) $ in Thousands					1 Months Ended	3 Months Ended			6 Months Ended		12 Months Ended
	Jul. 01, 2022 USD ($)	May 12, 2022 USD ($)	Jan. 13, 2021 USD ($)	Apr. 03, 2020 USD ($)	Jul. 31, 2022 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Mar. 31, 2021 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Dec. 31, 2021 USD ($)	Jul. 15, 2022 USD ($)	Dec. 31, 2020 USD ($)	Jul. 31, 2019 USD ($)	Sep. 10, 2018 USD ($)
Contract with Customer, Liability, Revenue Recognized									$ 3,000
The 19C BARDA Contract [Member]
Number of Courses to Be Delivered															1,488,000
Number of Courses Stored As Vendor Managed Inventory															212,000
Government Contract, Value of Award						$ 602,500			602,500
Government Contract, Base Period, Value of Award for Delivery and Support Activities						51,700			$ 51,700						$ 51,700
Base Period of Performance (Year)									5 years
Government Contract, Value, Payments Remaining Related to Exercised Options									$ 239,700
Government Contract, Value, Payments Currently Specified as Unexercised Options									$ 311,100
Base Period of Performance, Exercise of Options, Term (Year)									10 years
Government Contract, Base Period, Value of Award for Delivery and Support Activities, Delivery of Courses															$ 11,100
Government Contract, Base Period, Number of Deliveries															35,700
Government Contract, Base Period, Value of Award for Delivery and Support Activities, Manufacture of Courses															$ 8,000
Government Contract, Base Period, Value of Award for Delivery and Support Activities, Advanced Development															32,000
Government Contract, Base Period, Value of Award for Delivery and Support Activities, Supportive Procurement Activities															$ 600
Proceeds from Delivery of Courses									$ 11,100
Number of Courses Delivered									35,700
Proceeds from Other Base Period Activities									$ 15,500
Government Contract, Value of Unexercised Options, Supportive Procurement Activities						5,600			5,600
The 19C BARDA Contract [Member] | IV TPOXX [Member]
Government Contract, Base Period, Number of Courses Manufactured															20,000
Government Contract, Value, Payments Related to Unexercised Options, Delivery of Courses						225,100			225,100
Government Contract, Value, Payments Related to Unexercised Options, Funding of Post-Marketing Activities						$ 3,600			$ 3,600
Number of Manufacturing Steps						2			2
The 19C BARDA Contract [Member] | IV BDS [Member]
Government Contract, Base Period, Value of Award for Delivery and Support Activities, Manufacture of Courses															$ 3,200
Proceeds from the Manufacture of Courses									$ 3,200
Proceeds from the Delivery of Courses									4,300
Contract with Customer, Liability, Total											$ 3,200
Contract with Customer, Liability, Revenue Recognized									2,900
Government Contract, Value, Payments Currently Specified as Unexercised Options, Manufacture of Courses						$ 30,700			$ 30,700
Government Contract, Number of Options for Manufacture of Product						3			3
Government Contract, Courses Manufactured Upon Exercise of Options						64,000			64,000
The 19C BARDA Contract [Member] | IV FDP [Member]
Contract with Customer, Liability, Total						$ 300			$ 300
Government Contract, Value, Payments Currently Specified as Unexercised Options, Manufacture of Courses						$ 76,800			$ 76,800
Government Contract, Number of Options for Manufacture of Product						3			3
Government Contract, Courses Manufactured Upon Exercise of Options						64,000			64,000
The 19C BARDA Contract [Member] | Oral TPOXX [Member]
Number of Courses to Be Delivered													726,140
Government Contract, Value, Payments Related to Exercised Options, Procurement of Raw Materials						$ 225,100			$ 225,100				$ 11,200
Government Contract, Value, Payments Related to Exercised Options, Delivery of Courses													213,900
Government Contract, Value, Payments Related to Exercised Options, Funding of Post-Marketing Activities													$ 14,600
Proceeds for the Procurement of Raw Materials											112,500
Proceeds from Payments Received for Post-marketing Activities									7,600
IC BARDA [Member] | Transferred over Time [Member]
Contract with Customer, Liability, Revenue Recognized						1,300		$ 800
IC BARDA [Member] | Transferred at Point in Time [Member]
Proceeds from the Delivery of Courses									7,200
Contract with Customer, Liability, Revenue Recognized								$ 0	1,900	$ 1,700
U.S. Department of Defense (“DoD”) [Member] | Oral TPOXX [Member]
Government Contract, Value, Payments Currently Specified as Unexercised Options		$ 3,800
Contract with Customer, Liability, Revenue Recognized						3,600
Government Contract, Value Ordered		$ 3,600
International Procurement [Member]
Contract with Customer, Liability, Revenue Recognized						5,000			5,000
International Procurement [Member] | Oral TPOXX [Member]
Contract with Customer, Liability, Revenue Recognized						5,000
International Procurement [Member] | Oral TPOXX [Member] | Subsequent Event [Member]
Government Contract, Value of Award	$ 60,000
Government Contract, Value, Payments Currently Specified as Unexercised Options	6,000
Government Contract, Value, Payments Related to Unexercised Options, Delivery of Courses	60,000
International Procurement [Member] | Oral TPOXX [Member] | Subsequent Event [Member] | CANADA
Government Contract, Value of Award	39,000
International Procurement [Member] | Oral TPOXX [Member] | Subsequent Event [Member] | Europe, Asia Pacific and the Middle East [Member]
Government Contract, Value of Award	$ 21,000
Meridian Contract [Member]
Contract with Customer, Liability, Revenue Recognized							$ 6,900			10,300
Meridian Contract [Member] | Oral TPOXX [Member]
Government Contract, Value of Award			$ 33,000
Contract with Customer, Liability, Revenue Recognized											10,000
Government Contract, Term (Year)			5 years
Government Contract, Increased Value of Award			$ 45,000
Meridian Contract [Member] | Oral TPOXX [Member] | Subsequent Event [Member]
Contract with Customer, Liability, Revenue Recognized					$ 16,000
Government Contract, Award, Target Delivery Amount												$ 19,000
Canadian Contract [Member] | Meridian Medical Technologies [Member]
Contract with Customer, Liability, Revenue Recognized											$ 4,000
Government Contract, Term (Year)				4 years
Government Contract, Award, Target Delivery Amount						4,000			4,000
Other Commitment, Total				$ 14,000
Government Contract, Unexercised Options									6,000
The PEP Label Expansion R & D Contract with the Department of Defense [Member]
Government Contract, Value of Award														$ 19,500
Contract with Customer, Liability, Revenue Recognized						6,600	$ 500		8,900	$ 600
Government Contract, Increased Value of Award														27,000
Government Contract, Initial Award														$ 12,400
Contract with Customer, Liability, Remaining Revenue Recognized						$ 15,400			$ 15,400

Note 4 - Inventory - Inventory

Note 4 - Inventory - Inventory (Details) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Raw materials	$ 22,047	$ 22,047
Work in-process	9,287,024	17,453,358
Finished goods	7,122,311	2,034,974
Inventory	$ 16,431,382	$ 19,510,379

Note 5 - Property, Plant and _3

Note 5 - Property, Plant and Equipment (Details Textual) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Depreciation, Depletion and Amortization, Total	$ 256,237	$ 264,834

Note 5 - Property, Plant and _4

Note 5 - Property, Plant and Equipment - Property, Plant and Equipment (Details) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Property, plant and equipment, gross	$ 6,949,920	$ 6,987,596
Less - accumulated depreciation and amortization	(4,840,200)	(4,621,639)
Property, plant and equipment, net	2,109,720	2,365,957
Other Assets [Member]
Property, plant and equipment, gross	3,678,647	3,678,647
Leasehold Improvements [Member]
Property, plant and equipment, gross	2,420,028	2,420,028
Computer Equipment [Member]
Property, plant and equipment, gross	473,386	511,062
Furniture and Fixtures [Member]
Property, plant and equipment, gross	$ 377,859	$ 377,859

Note 6 - Accrued Expenses and_3

Note 6 - Accrued Expenses and Other Current Liabilities - Accrued Expenses and Other Current Liabilities (Details) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Deferred revenue	$ 7,035,354	$ 3,764,696
Research and development vendor costs	3,657,403	256,397
Compensation	1,424,067	2,811,700
Other	934,745	938,082
Professional fees	808,246	527,026
Inventory	477,875	488,081
Accrued expenses and other current liabilities	14,844,830	9,252,812
Accrued Expenses and Other Current Liabilities [Member]
Lease liability, current portion	$ 507,140	$ 466,830

Note 7 - Financial Instruments

Note 7 - Financial Instruments (Details Textual) $ / shares in Units, shares in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Dec. 31, 2021 USD ($) shares	Sep. 02, 2016 USD ($) $ / shares shares
(Gain) Loss on Change in Fair Value of Warrant Liability	$ (49,559)	$ (442,269)	$ (400,663)	$ (1,361,070)
Warrants and Rights Outstanding	0		$ 0		$ 6,521,441
The 2016 Warrant [Member]
Class of Warrant or Right Outstanding, Common Stock Value Used to Determine Number of Shares Called						$ 4,000,000
Class of Warrant or Right Outstanding, Common Stock Price Per Share Used to Determine Number of Shares Called (in dollars per share) | $ / shares						$ 2.29
Warrants and Rights Outstanding, Term (Year)						10 years
Class of Warrant or Right, Subscription Price of Warrants or Rights (in dollars per share) | $ / shares						$ 1.50
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares						$ 1.50
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares					1	2.7
(Gain) Loss on Change in Fair Value of Warrant Liability	$ 50,000
Warrants and Rights Outstanding					$ 6,500,000
The 2016 Warrant [Member] | Measurement Input, Expected Dividend Rate [Member]
Warrants and Rights Outstanding, Measurement Input	0		0		0
The 2016 Warrant [Member] | Measurement Input, Risk Free Interest Rate [Member]
Warrants and Rights Outstanding, Measurement Input					0.0121
The 2016 Warrant [Member] | Measurement Input, Expected Term [Member]
Warrants and Rights Outstanding, Measurement Input					4.7
The 2016 Warrant [Member] | Measurement Input, Price Volatility [Member]
Warrants and Rights Outstanding, Measurement Input					0.55

Note 8 - Fair Value of Financ_3

Note 8 - Fair Value of Financial Instruments (Details Textual) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Fair Value, Inputs, Level 1 [Member]
Cash and Cash Equivalents, Fair Value Disclosure	$ 100	$ 100
Fair Value, Inputs, Level 2 [Member]
Cash and Cash Equivalents, Fair Value Disclosure	$ 0

Note 8 - Fair Value of Financ_4

Note 8 - Fair Value of Financial Instruments - Changes in the Liability-classified Warrant Measured at Fair Value (Details)	6 Months Ended
	Jun. 30, 2022 USD ($)
Warrant liability	$ 6,521,441
Decrease in fair value of Warrant liability	(400,663)
Exercise of Warrant	(6,120,778)
Warrant liability	$ 0

Note 9 - Per Share Data (Detail

Note 9 - Per Share Data (Details Textual) - shares	3 Months Ended	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	51,930	53,353

Note 9 - Per Share Data - Recon

Note 9 - Per Share Data - Reconciliation of the Basic and Diluted Loss Per Share (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Net income (loss)	$ 2,037,062	$ 169,200	$ 1,676,012	$ (642,905)
Less: Change in fair value of warrants and cash-based RSUs	49,559	428,128	400,663	1,346,929
Net income/(loss), adjusted for change in fair value of warrants and cash-based RSUs for diluted earnings per share	$ 1,987,503	$ (258,928)	$ 1,275,349	$ (1,989,834)
Weighted average shares outstanding: basic (in shares)	72,678,333	75,810,641	72,873,366	76,281,211
Effect of potential common shares (in shares)	654,555	849,413	825,860	847,762
Weighted average shares outstanding: diluted (in shares)	73,332,888	76,660,054	73,699,226	77,128,973
Basic income/(loss) per share (in dollars per share)	$ 0.03	$ 0	$ 0.02	$ (0.01)
Diluted income/(loss) per share (in dollars per share)	$ 0.03	$ 0	$ 0.02	$ (0.03)

Note 9 - Per Share Data - Antid

Note 9 - Per Share Data - Antidilutive Securities Excluded from Computation (Details) - shares		3 Months Ended	6 Months Ended
		Jun. 30, 2022	Jun. 30, 2022	Jun. 30, 2021
Antidilutive securities (in shares)		51,930	53,353
Share-Based Payment Arrangement, Option [Member]
Antidilutive securities (in shares)			123,667	154,617
Restricted Stock Units (Stock Settled) [Member]
Antidilutive securities (in shares)	[1]		166,683	165,309
[1]For the three months ended March 31, 2022, this includes 54,792 units which are expected to settle in cash.

Note 10 - Commitments and Con_2

Note 10 - Commitments and Contingencies (Details Textual) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Cash and Cash Equivalents, at Carrying Value, Total	$ 114,530,926	$ 103,138,819
Fair Value, Inputs, Level 1 [Member]
Cash and Cash Equivalents, at Carrying Value, Total	$ 21,700,000

Note 11 - Related Party Trans_2

Note 11 - Related Party Transactions (Details Textual)		3 Months Ended	6 Months Ended
	May 26, 2017 USD ($) ft²	Jun. 30, 2022 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)
Outside Counsel [Member]
Legal Fees			$ 0	$ 100,000
Accounts Payable, Related Parties		$ 0	0
MacAndrews and Forbes Incorporated [Member] | The New HQ Lease [Member]
Lessee, Operating Lease, Term of Contract (Year)	10 years
Area of Real Estate Property (Square Foot) | ft²	3,200
Monthly Rent During Initial Period	$ 25,333
Monthly Rent, Initial Period (Month)	63 months
Monthly Rent After Initial Period	$ 29,333
Monthly Facility Fee, Second Year	$ 3,333
Monthly Facility Fee, Yearly Rate Increase After Second Year	5%
Monthly Facility Fee, Final Year	$ 4,925
Operating Lease, Expense		$ 100,000	$ 200,000

Note 12 - Revenues by Geograp_3

Note 12 - Revenues by Geographic Region - Revenues by Geographic Region (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Total revenues	$ 16,667,045	$ 8,653,289	$ 27,206,345	$ 13,467,033
UNITED STATES
Total revenues	11,715,302	1,673,083	22,254,602	2,911,455
Asia Pacific [Member]
Total revenues	4,929,423	0	4,929,423	0
CANADA
Total revenues	0	6,980,206	0	10,555,578
Other [Member]
Total revenues	22,320	0	22,320	0
Non-US [Member]
Total revenues	$ 4,951,743	$ 6,980,206	$ 4,951,743	$ 10,555,578

Note 13 - Income Taxes (Details

Note 13 - Income Taxes (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income (Loss) Attributable to Parent, before Tax, Total	$ 3,200,000	$ 500,000	$ 2,100,000	$ 600,000
Income Tax Expense (Benefit), Total	$ 1,155,581	$ 298,406	$ 452,175	$ 65,473
Effective Income Tax Rate Reconciliation, Percent, Total	36.20%	63.80%	21.20%	11.30%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21%		21%

Note 14 - Equity (Details Textu

Note 14 - Equity (Details Textual) - USD ($) $ / shares in Units, shares in Millions		3 Months Ended		6 Months Ended
	May 05, 2022	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Aug. 02, 2021
Stock Repurchase Program, Authorized Amount						$ 50,000,000
Stock Repurchased During Period, Shares (in shares)		0.5		1.5
Stock Repurchased During Period, Value		$ 3,576,922	$ 6,600,510	$ 10,149,704	$ 13,129,858
Special Dividend [Member]
Common Stock, Dividends, Per Share, Declared (in dollars per share)	$ 0.45
Dividends, Total	$ 32,900,000
New Repurchase Authorization [Member]
Stock Repurchase Program, Authorized Amount						$ 50,000,000
Stock Repurchased During Period, Shares (in shares)			1		1.9
Stock Repurchased During Period, Value			$ 6,600,000		$ 13,100,000

Note 14 - Equity - Changes in S

Note 14 - Equity - Changes in Stockholders' Equity (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Balances	$ 167,736,796	$ 122,684,867	$ 174,314,407	$ 129,793,269
Net income (loss)	$ 2,037,062	169,200	$ 1,676,012	(642,905)
Repurchase of common stock (in shares)	(500,000)		(1,500,000)
Repurchase of common stock	$ (3,576,922)	(6,600,510)	$ (10,149,704)	(13,129,858)
Issuance of common stock upon vesting of RSUs	0	0	0	0
Issuance of common stock upon exercise of warrants	6,120,778		6,120,778
Cash dividend ($0.45 per share)	(32,944,314)		(32,944,314)
Stock-based compensation	395,454	467,405	764,208	713,817
Payment of common stock tendered for employee stock-based compensation tax obligations			(12,533)	(13,361)
Net income (loss)	2,037,062	169,200	1,676,012	(642,905)
Balances	$ 139,768,854	$ 116,720,962	$ 139,768,854	$ 116,720,962
Common Stock [Member]
Balances (in shares)	72,566,367	76,240,439	73,543,602	77,195,704
Balances	$ 7,256	$ 7,625	$ 7,354	$ 7,720
Net income (loss)	$ 0	$ 0	$ 0	$ 0
Repurchase of common stock (in shares)	(494,979)	(956,022)	(1,474,781)	(1,913,927)
Repurchase of common stock	$ (49)	$ (96)	$ (147)	$ (191)
Issuance of common stock upon vesting of RSUs (in shares)	127,856	105,000	132,396	109,542
Issuance of common stock upon vesting of RSUs	$ 13	$ 10	$ 13	$ 10
Issuance of common stock upon exercise of warrants (in shares)	824,903		824,903
Issuance of common stock upon exercise of warrants	$ 82		$ 82
Cash dividend ($0.45 per share)	0
Stock-based compensation	0	0	$ 0	$ 0
Payment of common stock tendered for employee stock-based compensation tax obligations (in shares)			(1,973)	(1,902)
Payment of common stock tendered for employee stock-based compensation tax obligations			$ 0	$ 0
Net income (loss)	$ 0	$ 0	$ 0	$ 0
Balances (in shares)	73,024,147	75,389,417	73,024,147	75,389,417
Balances	$ 7,302	$ 7,539	$ 7,302	$ 7,539
Additional Paid-in Capital [Member]
Balances	226,426,529	225,211,481	226,070,308	224,978,430
Net income (loss)	0	0	0	0
Repurchase of common stock	0	0	0	0
Issuance of common stock upon vesting of RSUs	(13)	(10)	(13)	(10)
Issuance of common stock upon exercise of warrants	6,120,696		6,120,696
Cash dividend ($0.45 per share)	0		0
Stock-based compensation	395,454	467,405	764,208	713,817
Payment of common stock tendered for employee stock-based compensation tax obligations			(12,533)	(13,361)
Net income (loss)	0	0	0	0
Balances	232,942,666	225,678,876	232,942,666	225,678,876
Retained Earnings [Member]
Balances	(58,696,989)	(102,534,239)	(51,763,255)	(95,192,881)
Net income (loss)	2,037,062	169,200	1,676,012	(642,905)
Repurchase of common stock	(3,576,873)	(6,600,414)	(10,149,557)	(13,129,667)
Issuance of common stock upon vesting of RSUs	0	0	0	0
Issuance of common stock upon exercise of warrants	0		0
Cash dividend ($0.45 per share)	(32,944,314)		(32,944,314)
Stock-based compensation	0	0	0	0
Payment of common stock tendered for employee stock-based compensation tax obligations			0	0
Net income (loss)	2,037,062	169,200	1,676,012	(642,905)
Balances	(93,181,114)	(108,965,453)	(93,181,114)	(108,965,453)
AOCI Attributable to Parent [Member]
Balances	0	0	0	0
Net income (loss)	0	0	0	0
Repurchase of common stock	0	0	0	0
Issuance of common stock upon vesting of RSUs	0	0	0	0
Issuance of common stock upon exercise of warrants	0
Cash dividend ($0.45 per share)	0
Stock-based compensation	0	0	0	0
Payment of common stock tendered for employee stock-based compensation tax obligations			0	0
Net income (loss)	0	0	0	0
Balances	$ 0	$ 0	$ 0	$ 0

Note 14 - Equity - Changes in_2

Note 14 - Equity - Changes in Stockholders' Equity (Details) (Parentheticals) - $ / shares	3 Months Ended	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2022
Cash dividend, per share (in dollars per share)	$ 0.45	$ 0.45

Note 15 - Leases (Details Textu

Note 15 - Leases (Details Textual)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Dec. 31, 2019	May 26, 2017 ft²
Operating Lease, Cost	$ 100,000	$ 100,000	$ 300,000	$ 300,000
Operating Lease, Payments	$ 200,000	200,000	$ 300,000	$ 300,000
Operating Lease, Weighted Average Remaining Lease Term (Year)	4 years 1 month 6 days		4 years 1 month 6 days
Operating Lease, Weighted Average Discount Rate, Percent	4.53%		4.53%
Operating Lease, Liability, Total	$ 2,351,376		$ 2,351,376
Other Liabilities [Member]
Operating Lease, Liability, Total	$ 1,800,000		$ 1,800,000
Facilities and Office Space in Corvallis Oregon [Member]
Lessee, Operating Lease, First Renewal Term (Year)					2 years
Lessee, Operating Lease, Second Renewal Term (Year)					3 years
Increase (Decrease) in Operating Lease Liability		$ 700,000
The New HQ Lease [Member] | MacAndrews and Forbes Incorporated [Member]
Lessee, Operating Lease, Term of Contract (Year)						10 years
Area of Real Estate Property (Square Foot) | ft²						3,200

Note 15 - Leases - Future Undis

Note 15 - Leases - Future Undiscounted Cash Flows Under Operating Leases (Details)	Jun. 30, 2022 USD ($)
2022	$ 272,625
2023	669,048
2024	678,627
2025	406,994
2026	409,971
Thereafter	165,916
Total undiscounted cash flows under leases	2,603,181
Less: Imputed interest	(251,805)
Present value of lease liabilities	$ 2,351,376